{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:18:42Z","timestamp":1757701122252},"reference-count":28,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1620\/tjem.238.205","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T21:36:56Z","timestamp":1457127416000},"page":"205-212","source":"Crossref","is-referenced-by-count":9,"title":["Combination Therapy of Denosumab and Calcitriol for a Renal Transplant Recipient with Severe Bone Loss due to Therapy-Resistant Hyperparathyroidism"],"prefix":"10.1620","volume":"238","author":[{"given":"Yukihiro","family":"Wada","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Iyoda","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Iseri","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Arai-Nunota","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toma","family":"Hamada","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Tachibana","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Shibata","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Agarwal, M., Csongr\u00e1di, \u00c9., Koch, C.A., Juncos, L.A., Echols, V., Tapolyai, M. &amp; F\u00fcl\u00f6p, T. (2013) Severe symptomatic hypocalcemia after denosumab administration in an end-stage renal disease patient on peritoneal dialysis with controlled secondary hyperparathyroidism. <i>Br. J. Med. Med. Res.<\/i>, 3, 1398-1406.","DOI":"10.9734\/BJMMR\/2013\/2989"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bertoni, E., Rosati, A., Larti, A., Merciai, C., Zanazzi, M., Rosso, G., Gallo, M., Marcucci, R. &amp; Salvadori, M. (2006) Chronic kidney disease is still present after renal transplantation with excellent function. <i>Transplant. Proc.<\/i>, 38, 1024-1025.","DOI":"10.1016\/j.transproceed.2006.03.059"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Block, G.A., Bone, H.G., Fang, L., Lee, E. &amp; Padhi, D. (2012) A single-dose study of denosumab in patients with various degrees of renal impairment. <i>J. Bone Miner. Res.<\/i>, 27, 1471-1479.","DOI":"10.1002\/jbmr.1613"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chen, C.L., Chen, N.C., Hsu, C.Y., Chou, K.J., Lee, P.T., Fang, H.C. &amp; Renn, J.H. (2014) An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis. <i>J. Clin. Endocrinol. Metab.<\/i>, 99, 2426-2432.","DOI":"10.1210\/jc.2014-1154"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chen, C.L., Chen, N.C., Liang, H.L., Hsu, C.Y., Chou, K.J., Fang, H.C. &amp; Lee, P.T. (2015) Effects of denosumab and calcitriol on severe secondary hyperparathyroidism in dialysis patients with low bone mass. <i>J. Clin. Endocrinol. Metab.<\/i>, 100, 2784-2792.","DOI":"10.1210\/jc.2015-1259"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cohen, J.B., Gordon, C.E., Balk, E.M. &amp; Francis, J.M. (2012) Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis. <i>Transplantation<\/i>, 94, 1041-1048.","DOI":"10.1097\/TP.0b013e31826c3968"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Covic, A., Kothawala, P., Bernal, M., Robbins, S., Chalian, A. &amp; Goldsmith, D. (2009) Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. <i>Nephrol. Dial. Transplant.<\/i>, 24, 1506-1523.","DOI":"10.1093\/ndt\/gfn613"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Cummings, S.R., San Martin, J., McClung, M.R., Siris, E.S., Eastell, R., Reid, I.R., Delmas, P., Zoog, H.B., Austin, M., Wang, A., Kutilek, S., Adami, S., Zanchetta, J., Libanati, C., Siddhanti, S., et al. (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. <i>N. Engl. J. Med.<\/i>, 361, 756-765.","DOI":"10.1056\/NEJMoa0809493"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Dave, V., Chiang, C.Y., Booth, J. &amp; Mount, P.F. (2015) Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5. <i>Am. J. Nephrol.<\/i>, 41, 129-137.","DOI":"10.1159\/000380960"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Douthat, W.G., Chiurchiu, C.R. &amp; Massari, P.U. (2012) New options for the management of hyperparathyroidism after renal transplantation. <i>World J. Transplant.<\/i>, 2, 41-45.","DOI":"10.5500\/wjt.v2.i3.41"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Dusilova Sulkova, S., Horacek, J., Safranek, R., Gorun, P., Viklicky, O. &amp; Palicka, V. (2014) Denosumab associated with bone density increase and clinical improvement in a long-term hemodialysis patient. Case report and review of the literature. <i>Acta Medica<\/i> (<i>Hradec Kralove<\/i>), 57, 30-33.","DOI":"10.14712\/18059694.2014.6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Egbuna, O.I., Taylor, J.G., Bushinsky, D.A. &amp; Zand, M.S. (2007) Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. <i>Clin. Transplant.<\/i>, 21, 558-566.","DOI":"10.1111\/j.1399-0012.2007.00690.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Evenepoel, P., Cooper, K., Holdaas, H., Messa, P., Mourad, G., Olgaard, K., Rutkowski, B., Schaefer, H., Deng, H., Torregrosa, J.V., Wuthrich, R.P. &amp; Yue, S. (2014) A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism. <i>Am. J. Transplant.<\/i>, 14, 2545-2555.","DOI":"10.1111\/ajt.12911"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Farinola, N. &amp; Kanjanapan, Y. (2013) Denosumab-induced hypocalcaemia in high bone turnover states of malignancy and secondary hyperparathyroidism from renal failure. <i>Intern. Med. J.<\/i>, 43, 1243-1246.","DOI":"10.1111\/imj.12283"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ivashkiv, L.B., Zhao, B., Park-Min, K.H. &amp; Takami, M. (2011) Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8. <i>Ann. NY Acad. Sci.<\/i>, 1237, 88-94.","DOI":"10.1111\/j.1749-6632.2011.06217.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Jamal, S.A., Ljunggren, O., Stehman-Breen, C., Cummings, S.R., McClung, M.R., Goemaere, S., Ebeling, P.R., Franek, E., Yang, Y.C., Egbuna, O.I., Boonen, S. &amp; Miller, P.D. (2011) Effects of denosumab on fracture and bone mineral density by level of kidney function. <i>J. Bone Miner. Res.<\/i>, 26, 1829-1835.","DOI":"10.1002\/jbmr.403"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Jamal, S.A., Swan, V.J., Brown, J.P., Hanley, D.A., Prior, J.C., Papaioannou, A., Langsetmo, L. &amp; Josse, R.G.; Canadian Multicentre Osteoporosis Study Research Group (2010) Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. <i>Am. J. Kidney Dis.<\/i>, 55, 291-299.","DOI":"10.1053\/j.ajkd.2009.10.049"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Lewin, E. &amp; Olgaard, K. (2006) Parathyroidectomy vs calcimimetics for treatment of persistent hyperparathyroidism after kidney transplantation. <i>Nephrol. Dial. Transplant.<\/i>, 21, 1766-1769.","DOI":"10.1093\/ndt\/gfl283"},{"key":"19","doi-asserted-by":"crossref","unstructured":"McCormick, B.B., Davis, J. &amp; Burns, K.D. (2012) Severe hypocalcemia following denosumab injection in a hemodialysis patient. <i>Am. J. Kidney Dis.<\/i>, 60, 626-628.","DOI":"10.1053\/j.ajkd.2012.06.019"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Messa, P., Sindici, C., Cannella, G., Miotti, V., Risaliti, A., Gropuzzo, M., Di Loreto, P.L., Bresadola, F. &amp; Mioni, G. (1998) Persistent secondary hyperparathyroidism after renal transplantation. <i>Kidney Int.<\/i>, 54, 1704-1713.","DOI":"10.1046\/j.1523-1755.1998.00142.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Nakamura, T., Matsumoto, T., Sugimoto, T., Hosoi, T., Miki, T., Gorai, I., Yoshikawa, H., Tanaka, Y., Tanaka, S., Sone, T., Nakano, T., Ito, M., Matsui, S., Yoneda, T., Takami, H., et al. (2014) Clinical trials express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). <i>J. Clin. Endocrinol. Metab.<\/i>, 99, 2599-2607.","DOI":"10.1210\/jc.2013-4175"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Schlosser, K., Sitter, H., Rothmund, M. &amp; Zielke, A. (2004) Assessing the site of recurrence in patients with secondary hyperparathyroidism by a simplified Casanova autograftectomy test. <i>World J. Surg.<\/i>, 28, 583-588.","DOI":"10.1007\/s00268-004-7321-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Silverman, S. &amp; Christiansen, C. (2012) Individualizing osteoporosis therapy. <i>Osteoporos. Int.<\/i>, 23, 797-809.","DOI":"10.1007\/s00198-011-1775-y"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Talreja, D.B. (2012) Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment. <i>Journal of Drug Assessment<\/i>, 1, 30-33.","DOI":"10.3109\/21556660.2012.668504"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Torregrosa, J.V. (2013) Dramatic increase in parathyroid hormone and hypocalcemia after denosumab in a kidney transplanted patient. <i>Clin. Kidney J.<\/i>, 6, 122.","DOI":"10.1093\/ckj\/sfs158"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Tsubakihara, Y., Nishi, S., Akiba, T., Hirakata, H., Iseki, K., Kubota, M., Kuriyama, S., Komatsu, Y., Suzuki, M., Nakai, S., Hattori, M., Babazono, T., Hiramatsu, M., Yamamoto, H., Bessho, M., et al. (2010) 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. <i>Ther. Apher. Dial.<\/i>, 14, 240-275.","DOI":"10.1111\/j.1744-9987.2010.00836.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Ungprasert, P., Cheungpasitporn, W., Srivali, N., Kittanamongkolchai, W. &amp; Bischof, E.F. (2013) Life-threatening hypocalcemia associated with denosumab in a patient with moderate renal insufficiency. <i>Am. J. Emerg. Med.<\/i>, 31, 756. e1-2.","DOI":"10.1016\/j.ajem.2012.11.011"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Wada, Y., Kunimura, T., Sato, S., Hisayuki, T., Sato, M., Imataka, H., Yamashita, N., Akizawa, T. &amp; Moroboshi, T. (2008) Proliferating potential and apoptosis in the development of secondary hyperparathyroidism: a study based on Ki-67 immunohistochemical staining and the terminal dUTP nick-end labeling assay. <i>Ther. Apher. Dial.<\/i>, 12, 319-328.","DOI":"10.1111\/j.1744-9987.2008.00594.x"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/238\/3\/238_205\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:36:27Z","timestamp":1498275387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/238\/3\/238_205\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.238.205","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}